Teva-Capecitabine

  • Generic name

    capecitabine

  • Brand reference

    Xeloda®

  • Strength

    150 mg

  • DIN

    02400022

  • Therapeutic class

    Antineoplastic Agent

  • Therapeutic area

    Oncology

  • Package size

    Blister 60
    Bottle 60

  • Product code

    69231-0135
    69231-0035

  • UPC

    068510176530
    068510179937

  • Generic name:

    capecitabine

  • Brand reference:

    Xeloda®

  • Product code:

    69231-0135
    69231-0035

  • Strength

    150 mg

  • DIN

    02400022

  • UPC:

    068510176530
    068510179937

  • Therapeutic class

    Antineoplastic Agent

  • Therapeutic area:

    Oncology

  • Package size:

    Blister 60
    Bottle 60

Composition

Active ingredient

capecitabine


Non-medicinal ingredients

croscarmellose sodium, hypromellose, iron oxides (yellow and red), lactose anhydrous, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.

Product characteristics

  • Dosage form

    tablet

  • Shape

    oval, biconvex

  • Marking 1

    C

  • Marking 2

    150

  • Colour

    light peach

  • Secondary colour

    -

  • Scored

    -

  • Flavour

    -

  • Gluten

    no

  • Latex

    not applicable

Disclaimers

All information about raw materials and/or allergen information for Teva Canada’s products is obtained from our suppliers and/or third-party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third-party affiliates and/or change in suppliers of the active and inactive ingredients that may occur over time, and all information provided herein is based on our last records on file.

Our manufacturing sites are not certified gluten-free. Raw materials and finished products are not tested for the presence of gluten. Therefore, the presence of trace amounts of gluten in the raw materials and in the finished products cannot be excluded.

"Latex" refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging, or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process; however, this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and/or packaging facilities may be wearing latex gloves.

Product monograph/consumer information leaflet


View monograph

Notice

We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.

Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.